Marie Zedalis
Family · Moosic, PANPI 1063986313
Payments from drug & device makers
Across 214 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$638
- AbbVie$533
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$453
- Otsuka America Pharmaceutical, Inc.$391
- Johnson & Johnson$381
- Alkermes, Inc.$291
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,12099%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 21 | $638 |
| AbbVie | 26 | $533 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $453 |
| Otsuka America Pharmaceutical, Inc. | 19 | $391 |
| Johnson & Johnson | 29 | $381 |
| Alkermes, Inc. | 11 | $291 |
| Jazz Pharmaceuticals Inc. | 12 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $263 |
| Eisai Inc. | 10 | $235 |
| Bausch Health US, LLC | 8 | $156 |
| Indivior Inc. | 6 | $107 |
| Neos Therapeutics, LP | 7 | $97 |
| Merck | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Lundbeck LLC | 3 | $49 |
| Biogen | 3 | $42 |
| Avanir Pharmaceuticals, Inc. | 3 | $37 |
| OWP Pharmaceuticals, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$364
- ABILIFY ASIMTUFII$113
- ABILIFY MAINTENA$113
How this compares
$4,167 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 24 | $1,540 |
| Duloxetine Hcl | 19 | $1,210 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $459 |
| Trazodone Hcl | 16 | $131 |
| Pantoprazole Sodium | 20 | $128 |
| Gabapentin | 11 | $107 |
| Sertraline Hcl | 19 | $92 |
| Lisinopril | 13 | $45 |
| Levothyroxine Sodium | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other family in Moosic
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.